Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristina M Dahlem

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|June 21, 2011
Terry's nails: a window to systemic diseasesAmir M Nia, Stefan Ederer, Kristina M Dahlem, et al.
European Journal of Clinical Pharmacology|June 30, 2011
Clinical impact of fluvoxamine-mediated long QTU syndromeAmir M Nia, Kristina M Dahlem, Natig Gassanov, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 4, 2011
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot studyAmir M Nia, Natig Gassanov, Kristina M Dahlem, et al.
Plos One|December 24, 2010
Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertensionFikret Er, Stefan Ederer, Amir M Nia, et al.
Thescientificworldjournal|April 26, 2011
Local thrombolysis for successful treatment of acute stroke in an adolescent with cardiac myxomaNatig Gassanov, Amir M Nia, Kristina M Dahlem, et al.
Circulation|May 11, 2013
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)"Fikret Er, Amir M Nia, Henning Dopp, et al.
Circulation|June 28, 2012
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial)Fikret Er, Amir M Nia, Henning Dopp, et al.
International Journal of Cardiology|May 5, 2015
Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trialFikret Er, Erland Erdmann, Amir M Nia, et al.
JACC. Cardiovascular Interventions|February 6, 2016
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) TrialFikret Er, Kristina M Dahlem, Amir M Nia, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|June 21, 2011
Terry's nails: a window to systemic diseasesAmir M Nia, Stefan Ederer, Kristina M Dahlem, et al.
European Journal of Clinical Pharmacology|June 30, 2011
Clinical impact of fluvoxamine-mediated long QTU syndromeAmir M Nia, Kristina M Dahlem, Natig Gassanov, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 4, 2011
Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot studyAmir M Nia, Natig Gassanov, Kristina M Dahlem, et al.
Plos One|December 24, 2010
Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertensionFikret Er, Stefan Ederer, Amir M Nia, et al.
Thescientificworldjournal|April 26, 2011
Local thrombolysis for successful treatment of acute stroke in an adolescent with cardiac myxomaNatig Gassanov, Amir M Nia, Kristina M Dahlem, et al.
Circulation|May 11, 2013
Response to letter regarding article, "Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized Pilot RenPro-Trial (Renal Protection Trial)"Fikret Er, Amir M Nia, Henning Dopp, et al.
Circulation|June 28, 2012
Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial)Fikret Er, Amir M Nia, Henning Dopp, et al.
International Journal of Cardiology|May 5, 2015
Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trialFikret Er, Erland Erdmann, Amir M Nia, et al.
JACC. Cardiovascular Interventions|February 6, 2016
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) TrialFikret Er, Kristina M Dahlem, Amir M Nia, et al.
Pageof 1